Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ngind.com | |
Market Cap | 30.13 Cr. | |
Enterprise Value(EV) | 28.98 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 24.82 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 3.62 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 48.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 84.17 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.07 | Calculated using Price: 89.92 |
Dividend Yield | 3.89 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.34 Cr. | 3,350,500 Shares |
FaceValue | 10 | |
About NG Industries Ltd. | ||
The company's principal activity is to provide healthcare and medical services. The company facilitates through the treatments and services like, imaging, cardiology, endoscopy, neurology, pathology, orthopaedics, infertility, surgery, operation theatres, indoor ward and surgery. |
1 Day |
|
-0.66% |
1 Week |
|
+3.14% |
1 Month |
|
+12.55% |
3 Month |
|
+18.96% |
6 Month |
|
+12.05% |
1 Year |
|
+30.13% |
2 Year |
|
+92.14% |
5 Year |
|
+22.42% |
10 Year |
|
+49.87% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 10.66 | 9.97 | 10.63 | 9.81 | 7.18 | 9.86 | 14.44 | 5.04 | 13.41 | |
Return on Capital Employed (%) | 13.62 | 12.93 | 15.93 | 14.33 | 11.81 | 14.94 | 17.80 | 6.57 | 17.19 | |
Return on Assets (%) | 8.03 | 8.32 | 9.10 | 8.17 | 6.35 | 9.59 | 12.71 | 4.38 | 11.96 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 14 | 14 | 14 | 14 | 12 | 11 | 9 | 15 | 24 | 28 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | -2 | -2 | -2 | -1 | 2 | ||
Curr. Liab. | 3 | 3 | 3 | 3 | 2 | 2 | 5 | 2 | 2 | 3 | |
Minority Int. | |||||||||||
Equity & Liab. | 18 | 17 | 17 | 18 | 12 | 11 | 12 | 16 | 27 | 31 | |
Non Curr. Assets | 15 | 15 | 15 | 15 | 10 | 9 | 9 | 14 | 22 | 28 | |
Curr. Assets | 3 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 5 | 3 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 18 | 17 | 17 | 18 | 12 | 11 | 12 | 16 | 27 | 31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 14 | 15 | 17 | 17 | 17 | 18 | 19 | 12 | 18 | 19 | |
Other Income | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | |
Total Income | 14 | 15 | 17 | 17 | 18 | 18 | 19 | 12 | 20 | 27 | |
Total Expenditure | -11 | -12 | -14 | -15 | -15 | -15 | -16 | -11 | -16 | -17 | |
PBIDT | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 1 | 4 | 10 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
Exceptional Items | |||||||||||
PAT | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 8 | |
Adjusted EPS | 5 | 4 | 5 | 4 | 3 | 3 | 4 | 2 | 8 | 25 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 1 | -2 | |
Cash Fr. Inv. | -4 | 2 | -1 | -1 | -1 | -2 | -1 | -3 | 2 | 1 | |
Cash Fr. Finan. | 2 | -4 | -2 | -1 | -1 | -2 | -2 | 0 | -3 | 0 | |
Net Change | 0 | 0 | -1 | 0 | 0 | -1 | 1 | 0 | 1 | 0 | |
Cash & Cash Eqvt | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 1 |
Fri, 19 May 2023
Board Meeting Outcome for Board Meeting Outcome For Audited Annual Financial Results Dividend And Related Matters Board Meeting Outcome for Audited Annual Financial Results Dividend And Related Matters |
Fri, 19 May 2023
Financial Results For Quarter And Year Ended 31St March 2023 Financial Results for Quarter and Year ended 31st March 2023 |
Fri, 19 May 2023
Corporate Action-Board approves Dividend Board approves Dividend for the Financial year ended 31st March 2023 subject to approval of shareholders. |
Tue, 06 Jun 2023 |
|
S Making Lower Lows for 2 Days |
|
|
|